Growth and Tolerance of a Partially Hydrolyzed Infant Formula
1 other identifier
interventional
244
1 country
13
Brief Summary
The purpose of this research study is to compare the growth and tolerance of infants who consume either an infant formula with intact proteins or an infant formula with partially hydrolyzed proteins through approximately 12 months of age.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2021
Typical duration for not_applicable
13 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 28, 2021
CompletedFirst Submitted
Initial submission to the registry
September 8, 2021
CompletedFirst Posted
Study publicly available on registry
September 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 11, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 21, 2023
CompletedJanuary 23, 2024
January 1, 2024
1.1 years
September 8, 2021
January 22, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Rate of body weight gain
up to 120 days
Secondary Outcomes (13)
Body length
up to 365 days of age
Head circumference
up to 365 days of age
Growth Z scores
up to 365 days of age
Growth Z scores
up to 365 days of age
Growth Z scores
up to 365 days of age
- +8 more secondary outcomes
Study Arms (2)
A routine cow's milk-based infant formula
ACTIVE COMPARATORA routine cow's milk-based infant formula
A partially hydrolyzed cow's milk protein (PHP) infant formula
EXPERIMENTALA partially hydrolyzed cow's milk protein (PHP) infant formula
Interventions
A routine cow's milk-based infant formula
A partially hydrolyzed cow's milk protein (PHP) infant formula
Eligibility Criteria
You may qualify if:
- to 14 days of age at randomization
- singleton birth
- Gestational age of 37 to 42 weeks
- Birth weight of 2500 g (5lbs 8oz or more)
- Exclusively receiving infant formula for at least 24 hours prior to randomization
- Parent or legal guardian has full intention to exclusively feed study formula through 120 days of age
- Parent or legal guardian agrees not to enroll infant in another interventional clinical study while participating in this study
- Signed informed consent and authorization to use and disclose Protected Health information
You may not qualify if:
- History of underlying metabolic or chronic disease
- Evidence of feeding difficulties or history of formula intolerance
- Weight at Visit 1 is \<98% of birth weight
- Infant was born large for gestational age from a mother who was diabetic at childbirth
- Infant is immunocompromised
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (13)
Birmingham Pediatric Associates
Birmingham, Alabama, 35205, United States
Southeastern Pediatric Associates
Dothan, Alabama, 36305, United States
Visions Clinical Research-Tucson
Tucson, Arizona, 85712, United States
Northwest Arkansas Pediatric Clinic
Fayetteville, Arkansas, 72703, United States
The Children's Clinic of Jonesboro
Jonesboro, Arkansas, 72401, United States
PAS Research
Tampa, Florida, 33613, United States
Rophe Adult & Pediatric Medicine
Union City, Georgia, 30339, United States
Saltzer Health
Nampa, Idaho, 83686, United States
Springs Medical Research
Owensboro, Kentucky, 42303, United States
Meridian Clinical Research
Grand Island, Nebraska, 68803, United States
The Jackson Clinic
Jackson, Tennessee, 38305, United States
DCOL Center for Clinical Research
Longview, Texas, 75605, United States
PAS Research
McAllen, Texas, 78501, United States
Related Publications (1)
Fabrizio V, Abdelmagid SA, Bose A, Hale M, Hays EC, Hudson M, Hughes T, Leonard D, Rouse K, Sideri M, Walker J, Wampler JL, Yeiser M, Zhuang W, Wu SS. Partially hydrolyzed cow's milk protein formula with an added prebiotic is well-tolerated, safe, and supports age-appropriate growth in healthy term infants through one year of age: DBRCT. BMC Pediatr. 2026 Jan 13. doi: 10.1186/s12887-025-06454-2. Online ahead of print.
PMID: 41527066DERIVED
Study Officials
- STUDY DIRECTOR
Steven Wu, Medical Director
Mead Johnson Nutrition
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 8, 2021
First Posted
September 17, 2021
Study Start
August 28, 2021
Primary Completion
October 11, 2022
Study Completion
November 21, 2023
Last Updated
January 23, 2024
Record last verified: 2024-01